Optiscan is pleased to announce it has today accepted the first purchase order from Carl Zeiss for its neurosurgery systems.
As foreshadowed in the shareholder update of June 6, these are pre-production prototypes of Optiscan’s rigid endomicroscopy system for neurosurgery to be exclusively supplied to Carl Zeiss, the world’s number one supplier of neurosurgical visualisation equipment. The systems will facilitate the final steps in the regulatory process, and it is expected they will be deployed in clinical trials with key opinion leaders.
The order, valued at approximately $800,000, is expected to be fulfilled in August as assembly of the
prototypes is already largely complete.
This order marks a major milestone in the development of the neurosurgery market for Optiscan’s
technology in partnership with the relevant world leader, Carl Zeiss.
Optiscan is a global leader in microscopic imaging technologies for medical markets. Optiscan’s
unique and patented technologies enable high-powered microscopes to be miniaturised and used
inside the body. The technology enables microscopic imaging of up to 1000 times magnification to be
achieved. Doctors can use the technology to instantly see cellular level details of tissue without the
requirement to surgically remove tissue (biopsy).
Gus Holt, Chairman
Tel (613) 9538 3347
Bruce Andrew, CFO
Tel (613) 9538 3398
To know more about Optiscan Imaging Limited, please click here.